Elevated plasma sTIM-3 levels in patients with severe COVID-19

BACKGROUND: The pathogenesis of coronavirus disease 2019 (COVID-19) is still incompletely understood, but it seems to involve immune activation and immune dysregulation. OBJECTIVE: We examined the parameters of activation of different leukocyte subsets in COVID-19–infected patients in relation to di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueland, Thor, Heggelund, Lars, Lind, Andreas, Holten, Aleksander R., Tonby, Kristian, Michelsen, Annika E., Jenum, Synne, Jørgensen, Marthe J., Barratt-Due, Andreas, Skeie, Linda G., Nordøy, Ingvild, Aanensen Fraz, Mai Sasaki, Quist-Paulsen E, Else, Pischke, Søren E., Johal, Simreen K., Hesstvedt, Liv, Bogen, Mette, Fevang, Børre, Halvorsen, Bente, Müller, Fredrik, Bekken, Gry Kloumann, Mollnes, Tom E., Dudman, Susanne, Aukrust, Pål, Dyrhol-Riise, Anne M., Holter, Jan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503135/
https://www.ncbi.nlm.nih.gov/pubmed/32971109
http://dx.doi.org/10.1016/j.jaci.2020.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503135/
https://www.ncbi.nlm.nih.gov/pubmed/32971109
http://dx.doi.org/10.1016/j.jaci.2020.09.007

Ejemplares similares